8-K: U.S. Physical Therapy Announces Acquisition and Reports Strong Q4 2024 Results

U.S. Physical Therapy reports a strong fourth quarter and full year 2024, highlighted by a new acquisition in Wyoming and record patient visits, while also navigating cost challenges and Medicare rate reductions.

Summary

• U.S. Physical Therapy, Inc. (USPH) announced the acquisition of a physical therapy practice with three clinic locations in Wyoming, generating approximately $4.3 million in annual revenues and 23,000 annual visits.
• USPH acquired a 65% interest in the acquired company, with the current owners retaining a 35% ownership interest.
• The company reported strong fourth-quarter results, with revenue growing more than 32% and full-year revenue growing nearly 24% to approximately $97 million in the injury prevention business.
• Adjusted EBITDA for the fourth quarter of 2024 was $21.8 million, compared to $19 million in the prior year.
• The average visits per day were a record high at 31.7.
• The net rate was $104.73 in the fourth quarter of 2024, $1.05 per visit higher than the fourth quarter of last year, even with a 1.8% Medicare rate reduction.
• For the full year 2024, the average daily visits per clinic was 30.4, the highest amount for any full year in the company's history.
• The company expects full-year 2025 EBITDA to be in the range of $88 million to $93 million, accounting for a 2.9% Medicare rate reduction.
• In the fourth quarter alone, the company added approximately 70 clinics in a combination of acquisitions and de novo locations.

Sentiment

Score: 7

Explanation: The document presents a generally positive outlook, highlighting strong revenue growth, strategic acquisitions, and a healthy balance sheet. However, it also acknowledges challenges related to cost control and Medicare rate reductions, resulting in a moderately positive sentiment.

Positives

• The acquisition of the Wyoming practice expands USPH's service offerings.
• The company achieved record-high average visits per day, indicating strong demand for services.
• Net rate increased despite Medicare rate reductions, reflecting successful contract negotiations.
• The injury prevention business is experiencing strong growth.
• The company's balance sheet is in an excellent position, with a manageable debt level and a revolving credit facility.
• The board increased the quarterly dividend rate, signaling confidence in the company's financial performance.

Negatives

• The company faces challenges in controlling the cost per visit due to a competitive environment for hiring therapists.
• A 2.9% Medicare rate reduction in 2025 will negatively impact revenue and EBITDA.
• The PT margin was 17.9% in the fourth quarter of 24, compared to 19.5% in the fourth quarter of last year.
• The addition of Metro in the fourth quarter lowered the overall average rate due to their lower average rate of $102.54.

Risks

• The competitive environment for hiring therapists could continue to put pressure on costs.
• Further Medicare rate reductions could negatively impact revenue and profitability.
• The successful integration of acquired practices is crucial for achieving expected synergies.
• The company's ability to maintain and grow its market share depends on its ability to adapt to changing industry trends and patient needs.

Future Outlook

The company expects full-year 2025 EBITDA to be in the range of $88 million to $93 million, with continued growth in volume and the IIP business, despite a Medicare rate reduction.

Management Comments

• Chris Reading, Chairman and CEO, thanked clinicians, partners, and leadership for their work and highlighted the company's high net promoter score and Google Care ratings.
• Chris Reading stated that the industry has been in a tough wash cycle but that the company will emerge stronger.
• Graham Reeve, Chief Operating Officer-West, expressed excitement about welcoming the new partners in Wyoming into the USPH family.

Industry Context

The physical therapy industry is facing challenges related to reimbursement rates and staffing costs. USPH is focused on managing these challenges through contract negotiations, cost control measures, and strategic acquisitions.

Comparison to Industry Standards

• USPH's net promoter score of 93 is outstanding, indicating high patient satisfaction compared to industry averages.
• The company's focus on increasing reimbursement rates through contract negotiations aligns with industry best practices.
• The expansion into new industry verticals, such as the auto manufacturing sector, demonstrates a proactive approach to growth compared to competitors.

Stakeholder Impact

• Shareholders will benefit from the increased quarterly dividend rate.
• Employees will benefit from the company's investments in infrastructure and recruiting.
• Patients will benefit from the company's commitment to providing high-quality care.
• The company's strategic acquisitions and growth initiatives will create opportunities for suppliers and partners.

Next Steps

• The company will continue to focus on strategic acquisitions and de novo clinic openings.
• USPH will continue to negotiate reimbursement rates with commercial and other payers.
• The company will continue to implement cost control measures to improve profitability.
• USPH will focus on expanding its service offerings, including home-based therapy.

Key Dates